Health state utility values in major depressive disorder treated with pharmacological interventions: a systematic literature review

Table 3 Summary of adverse event disutilities from included studies

Author (year), Country	Population	Adverse event	Disutility estimate	Instrument
Revicki and Wood [33], Canada and United States	Patients with MDD who had completed at least 8 weeks of ADT or had completed an ADT regimen within the last 2 months prior to the study	Sedation	0.06^a	Standard gamble (patients)
		Nervousness	0.12
		Headache	0.09^a
		Constipation	0.05^a
		Tension	0.035^a
		Lightheaded/faint	0.12
		Dry mouth	0.01
		Nausea	0.01

ISSN: 1477-7525